mTOR Inhibition Increases Transcription Factor E3 (TFE3) Activity and Modulates Programmed Death-Ligand 1 (PD-L1) Expression in Translocation Renal Cell Carcinoma-Reference-Cited by-同舟云学术

mTOR Inhibition Increases Transcription Factor E3 (TFE3) Activity and Modulates Programmed Death-Ligand 1 (PD-L1) Expression in Translocation Renal Cell Carcinoma

Published:2021-11 Issue:11 Volume:191 Page:1999-2008
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Lee Hyun Jung^ORCID,Shin Dong Hoon,Song Ji Sun,Park Joon Young,Kim So Young^ORCID,Hwang Chung Su,Na Ju-Young^ORCID,Lee Jung Hee,Kim Jee Yeon,Park Sung Woo,Sol Mee Young

Funder

National Cancer Institute

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference39 articles.

1. Xp11 translocational renal cell carcinoma in adults: expanded clinical, pathological and genetic spectrum;Argani;Am J Surg Pathol,2007

2. Long-term treatment with sequential molecular targeted therapy for Xp11.2 tranloscation renal cell carcinoma: a case report and review of the literature;Kakoki;Clin Genitourin Cancer,2017

3. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

4. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma;Motzer;N Engl J Med,2018

5. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris;Martina;Sci Signal,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy;Molecular Cancer;2024-09-02

2. TFE3/PI3K/Akt/mTOR Axis in Renal Cell Carcinoma Affects Tumor Microenvironment;The American Journal of Pathology;2024-07

3. Pregnant patient with Xp11.2/transcription factor E3 translocation renal cell carcinoma: a case report and literature review;Frontiers in Oncology;2024-06-26

4. TET activity safeguards pluripotency throughout embryonic dormancy;Nature Structural & Molecular Biology;2024-05-23

5. Geroscience and pathology: a new frontier in understanding age-related diseases;Pathology and Oncology Research;2024-02-23